Stock Groups

Georgia reverses course, joins $26 billion U.S. opioid settlement -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILEPHOTO: Hydrocodone, an opioid-based painkiller, is being sold at Portsmouth’s pharmacy on June 21, 2017. REUTERS/Bryan Woolston

(Reuters) – The state of Georgia has reversed course and decided to join a proposed $26 billion nationwide settlement resolving lawsuits alleging that three large drug distributors and the drugmaker Johnson & Johnson (NYSE:) fueled the deadly U.S. opioid epidemic.

Friday’s announcement by Georgia Attorney General Chris Carr marked the latest instance of a holdout state opting into the landmark agreements with J&J, McKesson Corp (NYSE:), AmerisourceBergen (NYSE:) Corp and Cardinal Health Inc (NYSE:).

Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, futures, indexes or Forex. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. Because prices might not reflect the market, they may be incorrect. This means that prices cannot be considered indicative and are inappropriate for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information, including buy/sell signal data. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.

[ad_2]